Skip to content

Kodiak Sciences Inc KOD Change in Other Assets

Change in Other Assets at other companies

Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
-$141K-12.8%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$357K+109%
Vera Therapeutics logo
Vera TherapeuticsVERA
$5.14M-12.5%
Immunome logo
ImmunomeIMNM
$5.1M+199%
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$11.73M+257%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$3M

Other financials

Income statement

See full
Operating income-$59.8M-1.2%
Net income-$58.2M-1.2%
EPS (diluted)-$0.94+13.8%

Balance sheet

See full
Cash & equivalents$169.5M+22.1%
Total debt$56.0M-17.2%
Total equity$112.1M+3.0%
Total assets$306.0M+2.7%

Cash flow

See full
Operating cash flow-$40.0M-37.6%
CapEx$942.0K+249%
Free cash flow-$41.0M-39.5%

Valuation

See full
Market cap$2.32B+1,477%
Enterprise value$2.2B+2,798%

Returns & leverage

See full
Return on equity-208.8%+2,306pp
Debt / equity0.5×-0.1×
Current ratio3.5×-1.1×

Where this comes from

Reported directly by Kodiak Sciences Inc in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kodiak Sciences Inc's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kodiak Sciences Inc's change in other assets?
Kodiak Sciences Inc (KOD) reported change in other assets of $975K in Q1 2026.
How has Kodiak Sciences Inc's change in other assets changed year-over-year?
Kodiak Sciences Inc's change in other assets increased by 3582.1% year-over-year, from -$28K to $975K.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.